Clinical Trials in Austin

Showing 8881-8900 of 11,561 trials

Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

NCT02735603

The purpose of this study is to evaluate the potential effect of naltrexone and bupropion extended-release combination on cardiac repolarization in healthy participants.

Heart Repolarization

Orexigen Therapeutics, Inc84 participantsStarted Apr 2016

Austin, Texas, United States

COMPLETEDPhase 4< 1 mile

Study Of Patients With Allergic Rhinitis And Asthma

NCT00296530

This study will last up to 6 weeks. Subjects will visit the clinic up to 5 times. Certain clinic visits will include a physical examination, medical history review, and lung function tests. All study related medications and medical examinations will be provided at no cost to the subject. The drugs used in this study are approved for the age group under study.

Asthma

GlaxoSmithKline600 participantsStarted Sep 2005

Ozark, Alabama, United States • Tempe, Arizona, United States • Little Rock, Arkansas, United States +77 more locations

Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

Study Of Patients With Allergic Rhinitis And Asthma

Find Trials by Condition in Austin

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.

A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

Dose Finding Study of HP802-247 in Venous Leg Ulcers

Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension

Preventing Relapse Following Involuntary Smoking Abstinence

A Comparison of Long-acting Injectable Medications for Schizophrenia

Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant

A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

The T REX Pilot Study: a Study to Investigate the Use of an Alternative Anaesthetic in Infants.

Evaluation of Repeat Administration of Purified Poloxamer 188

Study In Patients With Dyslipidaemia

A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy

ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood